Effect of Antifibrotic Use on Mortality in Patients with Idiopathic Pulmonary Fibrosis.

Huiping XuSiu L HuiJoyce S LeeZuoyi ZhangRyan D Boente

Published in: Annals of the American Thoracic Society (2024)

Findings in this study did not confirm an association between antifibrotics and mortality, with a stratified analysis showing support for a potential treatment effect with early treatment initiation.

Keyphrases

idiopathic pulmonary fibrosis
cardiovascular events
risk factors
risk assessment
systemic sclerosis